Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Salivary Gland Neoplasms 1Brain Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Specimen Handling 4Docetaxel 3pertuzumab 2pembrolizumab 2Trastuzumab 2Taxes 2Paclitaxel 2High-Energy Shock Waves 2Cyclophosphamide 2Carboplatin 2Biopsy 2trastuzumab biosimilar HLX02 1fisetin 1Watchful Waiting 1Surgical Procedures, Operative 1Simvastatin 1PF-05280014 1Ontruzant 1Ogivri 1Observation 1Minoxidil 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunoglobulin G 1Educational Status 1Early Intervention, Educational 1Doxorubicin 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anatomic Stage I Breast Cancer AJCC v8 × Ontruzant × Clear all
NCT04329065 2026-05-19

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

University of Washington

Phase 2 Recruiting
25 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡